James C Keith

Quinic acid derivatives as sialyl Lewis(x)-mimicking selectin inhibitors: design, synthesis, and crystal structure in complex with E-selectin.

Bert E Thomas, J. Alvarez, W. Somers, 2005, Journal of medicinal chemistry.

Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands.

Iwan Gunawan, Eric S Manas, M. Malamas, 2004, Journal of medicinal chemistry.

Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity.

R. Bhat, R. Winneker, J. Keith, 2005, Proceedings of the National Academy of Sciences of the United States of America.

2-(4-Chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[H]quinoline-4-carboxylic acid (PSI-697): identification of a clinical candidate from the quinoline salicylic acid series of P-selectin antagonists.

A. Moretto, G. Shaw, R. Schaub, 2007, Journal of medicinal chemistry.

Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk.

G. Feuerstein, A. Struthers, J. Keith, 2008, Cardiovascular therapeutics.

Synthesis and biological evaluation of quinoline salicylic acids as P-selectin antagonists.

Adam Shilling, J. Keith, A. Shilling, 2007, Journal of medicinal chemistry.